CAPRI National Juvenile Idiopathic Arthritis Registry

NCT03245801 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1238

Last updated 2025-06-25

No results posted yet for this study

Summary

Juvenile Idiopathic Arthritis (JIA) is a disorder of unknown cause characterized by chronic inflammation of the joints and other organs. It affects about 1 in a 1000 Canadian children and if untreated it can produce lifelong disability. The Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) includes most pediatric rheumatologists in Canada. They have successfully collaborated for the past 20 years producing groundbreaking research on the modern course and outcomes of JIA. The CAPRI JIA Registry is an ongoing universal registry of Canadian children with JIA that collects longitudinal data on disease course, outcomes and adverse events to inform healthcare decisions and to gain new insights into the disease and its treatment.

Conditions

  • Juvenile Idiopathic Arthritis (JIA)

Sponsors & Collaborators

  • Children's Hospital of Eastern Ontario

    collaborator OTHER
  • The Hospital for Sick Children

    collaborator OTHER
  • IWK Health Centre

    collaborator OTHER
  • London Health Sciences Centre

    collaborator OTHER
  • Royal University Hospital Foundation

    collaborator OTHER
  • University of Manitoba

    collaborator OTHER
  • University of Calgary

    collaborator OTHER
  • Alberta Children's Hospital

    collaborator OTHER
  • Memorial University of Newfoundland

    collaborator OTHER
  • McMaster University

    collaborator OTHER
  • McMaster Children's Hospital

    collaborator OTHER
  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    collaborator OTHER
  • Université de Montréal

    collaborator OTHER
  • Laval University

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Jaime Guzman, MD, FRCPC · University of British Columbia

  • Adam Huber, MD · IIWK Health Centre, Halifax, Nova Scotia, Canada

  • Ciaran Duffy, MD · Children's Hospital of Eastern Ontario, Ottawa, Ontario

  • Gaëlle Chédeville, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Heinrike Schmeling, MD · Alberta Children's Hospital

  • Linda Hiraki, MD,FRCPC,MS · Hospital for Sick Children (SickKids)

  • Heinrike Schmeling, MD · University of Calgary / Alberta Children's Hospital

  • Susanne Benseler, MD, PhD · University of Calgary / Alberta Children's Hospital

  • Marinka Twilt, MD MSCE PhD · University of Calgary / Alberta Children's Hospital

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245801 on ClinicalTrials.gov